BCL2L1 and non-Hodgkin lymphoma: In non-Hodgkin's lymphoma (NHL) B cells, recombinant APRIL activates NF- μB, upregulates the anti-apoptotic proteins Bcl-2 and Bcl-xL, and downregulates the pro-apototic protein Bax to inhibit apoptosis [14].